胰腺癌多学科协作诊疗模式的发展及协和经验
Multidisciplinary Treatment of Pancreatic Cancer:Development and Experience of PUMCH
陈远 1徐强 1王维斌 1张太平 1郭俊超1
作者信息
- 1. 中国医学科学院北京协和医院 基本外科,北京 100730;中国医学科学院北京协和医院 疑难重症及罕见病国家重点实验室,北京 100730
- 折叠
摘要
胰腺癌是常见的消化道恶性肿瘤,早期诊断困难及缺乏有效的治疗手段是胰腺癌预后不良的主要原因.近年来,多学科协作诊疗(multidisciplinary treatment,MDT)成为突破胰腺癌诊治瓶颈、改善临床预后的重要手段.在为患者提供优质诊疗服务的基础上,该诊疗模式有助于专科医师临床诊治水平的提升和高素质复合型医学人才的培养,同时兼顾临床科研入组和优质病例资源共享,并推动创新药物及新型诊疗技术的临床应用,对增加医院核心竞争力具有良好促进作用.本文就我国胰腺癌MDT模式的起源、发展现状、存在的不足进行回顾与总结,并对未来发展进行展望,以期为国内外同行提供参考和借鉴.
Abstract
Pancreatic cancer is a common malignant tumor in the digestive tract,and the difficulty of early diagnosis and the lack of effective treatment means are the main reasons for the poor prognosis of pancreat-ic cancer.In recent years,multidisciplinary treatment(MDT)has become an important means to break through the bottleneck of diagnosis and treatment of pancreatic cancer and improve clinical prognosis.Besides providing patients with high-quality diagnosis and treatment services,this treatment model helps to improve the clinical diagnosis and treatment level of specialists and cultivate high-quality compound medical talents.It also high-lights clinical research groups and high-quality case resource sharing,and promotes the clinical application of innovative drugs and new diagnostic and therapeutic technologies,which plays an essential role in increasing the core competence of hospitals.This paper reviews and summarizes the origin,status quo,and deficiencies of the MDT diagnosis and treatment model of pancreatic cancer in China,and examines the prospects for future development,with the aim to provide reference for domestic and foreign counterparts.
关键词
胰腺癌/多学科协作诊疗/发展历史/疑难疾病Key words
pancreatic cancer/multidisciplinary treatment/development history/difficult and complex disease引用本文复制引用
基金项目
中国医学科学院医学与健康科技创新工程(2021-I2M-1-002)
中国医学科学院医学与健康科技创新工程(2022-I2M-C&T-B-030)
中央高水平医院临床科研专项(2022-PUMCH-D-001)
中央高水平医院临床科研专项(2022-PUMCH-B-004)
出版年
2024
国家科技期刊平台
NSTL
万方数据